April 07, 2026
Biosimilars Market ( By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins; By Application: Chronic & Autoimmune Disorders Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Others; By Regi...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
April 21, 2026
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com